Skip to main content
SpringerLink
Log in

Antineoplastics/folinic-acid

Proteinuria and delayed onset-diarrhoea: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Zhao X, et al. Efficacy and safety of FOLFIRI regimen with or without bevacizumab in the treatment of metastatic GEP-NEC. Journal of Practical Oncology 31: 462-468, No. 5, 10 Oct 2016 [Chinese; summarised from atranslation] - China

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics/folinic-acid. Reactions Weekly 1633, 71 (2017). https://doi.org/10.1007/s40278-017-24342-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-24342-7

Search

Navigation